Clinical Trial Update: Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB [Phase 4]

View source ↗

Summary

Long-term safety and efficacy data for Tenofovir Amibufenamide in chronic hepatitis B from a Phase 4 trial, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir Amibufenamide (tenofovir amibufenamide)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 4 | Status: ACTIVE_NOT_RECRUITING